Ortega González E, Domínguez-Hernández R, Martínez Roma M, Ocete-Mochone MD, Carrodeguas A, González-Sánchez JL, Casado MA, García Deltoro M
Value of public health interventions for HIV, HBV and HCV integrated screening: The FOCUS-CRIVALVIR programme
Ann Epidemiol. 2025;109:31-37. doi: 10.1016/j.annepidem.2025.06.014
Buti M, Cabezas J, Domínguez-Hernández R, Cantero H, Casado MA
Socioeconomic Impact of Chronic Delta Hepatitis in Spain: Indirect Costs of Work Absenteeism, Presenteeism, and Premature Mortality
PLoS One. 2025;20(6):e0324834. doi: 10.1371/journal.pone.0324834
Cabezas J, Aguilera A, García F, Domínguez-Hernández R, Casado-Gómez A, Espinoza-Cámac N, Casado MA, Crespo J. On behalf of Task force Spanish Group for com-prehensive hepatitis diagnosis
Comprehensive diagnosis of viral hepatitis in Spain: Bases for implementation
Viruses. 2025;17(5):667. doi: 10.3390/v17050667
Fuentes A, Estévez-Escobar M, De Salazar A, Ruiz Escolano E ,Montiel N, Macías M, Alados JC, Aguilar JC, Pérez AB, Barrera Baena P, Cabezas T, Camelo-Castillo A, Palop B, González Grande R, Viciana I, Pinazo JM Bandera, Fernández Sánchez F, Lozano MC, Giráldez A, Domínguez MC, Jimeno Maté C, Ramírez Arellano E, Cordero P, Franco Álvarez De Luna F, del Pino P, De la Iglesia Salgado A, Pérez D, Sampedro A, López Garrido MA, Luzón-García MP, Salas-Coronas J, Roldán C, García F, Freyre C, Santamaría Rodríguez G, Rosales-Zabal JM, Domínguez-Hernández R, Casado MA, García F
Double reflex testing improvesthe efficacy and cost effectivenessof hepatitis delta diagnosis insouthern Spain
Sci Rep. 2025 May 2;15(1):15413
Forns X, Rodríguez M, Domínguez-Hernández R, Cantero H, Salinas-Ortega L, Ángel Casado M
Cost analysis of hidden hepatitis D virus infection in Spain
Gastroenterología y Hepatología. https://doi.org/10.1016/j.gastrohep.2025.502337
Castro Urda JL, Álvarez M, Cantero H, Ayala V, Vázquez M, Castro J, Salinas-Ortega L, Domínguez-Hernández R
The efficiency of artificial intelligence for management and clinical decision-making in the identification of patients with undiagnosed HCV infection (Intelligen-C strategy)
Gastroenterología y Hepatología. https://doi.org/10.1016/j.gastrohep.2025.502362
Aguilera V, González-Grande R, Pena MJ, Bono A, Granados R, Jiménez-Pérez M, Serrano M, Cantero H, González-de-Adalid C, Sainz M, Espinoza Cámac N, Domínguez-Hernández R
Efficiency of the Relink C strategy: identification and retrieval of chronic HCV patients full and partial diagnosed but unlinked to care
Medical Research Archive. https://doi.org/10.18103/mra.v12i12.6149
Tajada P, Villalta V, Gómez-Chacón L, Monge D, Álvarez M, Heredia B, Calvo M, Herrera L, Caro MR, Salinas L, Casado A, Casado MA
Estrategia de detección precoz de hepatitis víricas en pacientes con solicitud de perfil bioquímico hepático e hipertransaminasemia
Semergen 51(2025):102339. doi: 10.1016/j.semerg.2024.102339
Buti M, Calleja JL, Rodríguez MÁ, Domínguez-Hernández R, Cantero H, Espinoza-Cámac N, Casado MÁ